Director Alison Mosca awarded 4,201 Clene (CLNN) stock options at $4.73

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Clene Inc. director Alison Mosca received a grant of stock options as equity compensation. On February 19, 2026, she was awarded options for 4,201 shares of common stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vested immediately upon grant, giving her the right to purchase the underlying shares at this fixed price.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Mosca Alison

Role Director

Type	Security	Shares	Price	Value
Grant/Award	stock option	4,201	$0.00	--

Holdings After Transaction: stock option — 4,201 shares (Direct)

Footnotes (1)

[object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/20/2026 - 04:04 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mosca Alison

(Last)

(First)

(Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY

84121

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
stock option	$4.73	02/19/2026		A		4,201		⁽¹⁾	02/18/2036	common stock	4,201	$0	4,201	D

Explanation of Responses:

1. This option was granted on February 19, 2026 as an option for 4,201 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share. The options vest immediately upon grant.

	/s/ Jerome T. Miraglia POA	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Clene (CLNN) report for Alison Mosca?

Clene reported that director Alison Mosca received a grant of stock options. She was awarded options for 4,201 shares of common stock, vesting immediately, under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $4.73 per share.

How many Clene (CLNN) shares are covered by Alison Mosca’s new stock options?

The new stock option grant covers 4,201 shares of Clene common stock. These options were issued under the Clene Inc. Amended 2020 Stock Plan and give her the right to buy those shares at a fixed exercise price of $4.73 per share.

What is the exercise price of Alison Mosca’s Clene (CLNN) stock options?

The exercise price of the options granted to Alison Mosca is $4.73 per share. This means she can purchase up to 4,201 shares of Clene common stock at $4.73, regardless of future market price, subject to the plan’s terms.

When do Alison Mosca’s Clene (CLNN) stock options vest?

The stock options granted to Alison Mosca vest immediately upon grant. According to the disclosure, the option for 4,201 shares of Clene common stock became fully vested on February 19, 2026, the same date it was awarded under the company’s stock plan.

Is Alison Mosca’s Clene (CLNN) option grant a purchase or an award?

The transaction is an award, not an open-market purchase. It is reported with code “A” as a grant or other acquisition of a derivative security, giving her options on 4,201 shares at a $4.73 exercise price under the company’s stock plan.

What plan governs Alison Mosca’s new Clene (CLNN) stock options?

The options were granted under the Clene Inc. Amended 2020 Stock Plan. This plan governs the terms of the award, including the number of optioned shares, the $4.73 exercise price per share, and the immediate vesting on the grant date.